• Pharma
  • November 6, 2023
  • 14 views
GC Biopharma Applies For MFDS Approval Of World’s First “Recombinant Anthrax Vaccine”

YONGIN, South Korea:  GC Biopharma announced 1 Nov. 2023 that it has applied for the marketing approval of “GC1109”, an anthrax vaccine jointly developed by GC Biopharma and the Korea Disease Control and…